Spondylarthritis Clinical Trial
— MISIA 2Official title:
Incidence of Sacro-iliac (SI) Joint Anomalies on MRI: Differentiation Criteria in Women With Spondyloarthritis (SpA
Verified date | July 2021 |
Source | University Hospital, Montpellier |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Retrospective study comparing the incidence of inflammatory and structural lesions seen on MRI of the sacro-iliac (SI) joints in a population of women affected by spondyloarthritis (SpA) and control women population (MISIA study NCT02956824). A previous study (MISIA) demonstrate SpA may be misdiagnosed on MRI in postpartum women due to increased stress on the joint following pregnancy and childbirth, as MRI of the SI joints may show lesions that could mimics SpA. The primary objective of this study is to compare the incidence and pattern of MRI inflammatory and structural lesions of the SI joints between SpA and control women, and determine differentiation criteria in SpA women.
Status | Enrolling by invitation |
Enrollment | 530 |
Est. completion date | March 30, 2022 |
Est. primary completion date | December 1, 2021 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion criteria: - Women aged 18 to 50 years old - SpA diagnosed - Pelvis MRI performed Exclusion criteria: - Pelvis MRI unavailable |
Country | Name | City | State |
---|---|---|---|
France | Uhmontpellier | Montpellier |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of MRI inflammatory of the sacroiliac joints | MRI inflammatory of the sacroiliac joints in the population of women affected by SpA | day 1 | |
Secondary | Rate of structural lesions of the sacroiliac joints | structural lesions of the sacroiliac joints in the population of women affected by SpA | day 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05494203 -
Multi-omics Study and Drug Intervention Study of Spondyloarthritis
|
||
Completed |
NCT03818958 -
Seric Calprotectine in Spondyloarthritis
|
||
Completed |
NCT01947465 -
Immunogenicity and Safety of Vaccinations in Immunocompromised Persons
|
N/A | |
Recruiting |
NCT05926453 -
Assessment of Cardiorespiratory Fitness in Spondylarthritis
|
||
Recruiting |
NCT05080218 -
COVID-19 VaccinE Response in Rheumatology Patients
|
Phase 4 | |
Terminated |
NCT03454932 -
Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
|
||
Completed |
NCT01314547 -
Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort
|
N/A | |
Not yet recruiting |
NCT06273306 -
Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC)
|
N/A | |
Recruiting |
NCT02809781 -
A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis
|
Phase 2/Phase 3 | |
Completed |
NCT02098694 -
Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis
|
N/A | |
Recruiting |
NCT00491933 -
Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists
|
N/A | |
Completed |
NCT02473315 -
Assessment of Whole Body Cryotherapy in Treatment of Active Axial Spondylarthritis
|
N/A | |
Completed |
NCT03999489 -
Study of the Psychometric Properties and a Measure of Utility Determinants ( the SF- 6D) in Patients With Early Inflammatory Low Back Pain
|
||
Recruiting |
NCT04519866 -
Clinical Trial of Electroacupuncture in Axial Spondyloarthritis (E-AcuSpA)
|
N/A | |
Completed |
NCT02402894 -
Follow-up of Person-centered Care of Young Adults With Rheumatic Disease
|
||
Recruiting |
NCT05592574 -
IL17 Rate and Spondyloarthritis
|
||
Completed |
NCT02988674 -
A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation
|
||
Recruiting |
NCT05555433 -
Calprotectine in Spondyloarthritis
|
||
Recruiting |
NCT06460805 -
axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis
|
N/A | |
Completed |
NCT01302730 -
Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study
|
N/A |